Related Experiment Video
Updated: Aug 3, 2025

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Interactome dynamics of RAF1-BRAF kinase monomers and dimers
Luis F Iglesias-Martinez1, Nora Rauch1, Kieran Wynne1
1Systems Biology Ireland, School of Medicine, University College Dublin, Dublin, Ireland.
Abstract:
RAF kinases play major roles in cancer. BRAFV600E mutants drive ~6% of human cancers. Potent kinase inhibitors exist but show variable effects in different cancer types, sometimes even inducing paradoxical RAF kinase activation. Both paradoxical activation and drug resistance are frequently due to enhanced dimerization between RAF1 and BRAF, which maintains or restores the activity of the downstream MEK-ERK pathway. Here, using quantitative proteomics we mapped the interactomes of RAF1 monomers, RAF1-BRAF and RAF1-BRAFV600E dimers identifying and quantifying >1,000 proteins. In addition, we examined the effects of vemurafenib and sorafenib, two different types of clinically used RAF inhibitors. Using regression analysis to compare different conditions we found a large overlapping core interactome but also distinct condition specific differences. Given that RAF proteins have kinase independent functions such dynamic interactome changes could contribute to their functional diversification. Analysing this dataset may provide a deeper understanding of RAF signalling and mechanisms of resistance to RAF inhibitors.
Insights
RAF kinases are key in cancer, but inhibitors can cause resistance via RAF1-BRAF dimerization. This study maps protein interactions to understand RAF signaling and drug resistance mechanisms.
Area of Science:
- Molecular Biology
- Oncology
- Proteomics
Background:
- RAF kinases are crucial in cell signaling and cancer development.
- BRAFV600E mutations drive approximately 6% of human cancers.
- Current RAF inhibitors have variable efficacy and can induce paradoxical activation, often linked to RAF1-BRAF dimerization.
Purpose of the Study:
- To map the interactomes of RAF1 monomers and RAF1-BRAF/BRAFV600E dimers.
- To investigate the impact of RAF inhibitors (vemurafenib, sorafenib) on these interactomes.
- To elucidate the role of dynamic interactome changes in RAF signaling and drug resistance.
Main Methods:
- Quantitative proteomics to identify and quantify interacting proteins.
- Analysis of RAF1 monomers, RAF1-BRAF dimers, and RAF1-BRAFV600E dimers.
- Comparative analysis using regression to assess interactome differences under various conditions, including drug treatment.
Main Results:
- Identified and quantified over 1,000 proteins in the RAF interactomes.
- Revealed a substantial overlapping core interactome across different RAF states.
- Detected distinct, condition-specific differences in protein interactions, influenced by dimerization and drug treatment.
Conclusions:
- Dynamic changes in the RAF interactome, including kinase-independent functions, contribute to functional diversification.
- Understanding these interactome dynamics is vital for deciphering RAF signaling pathways.
- This research provides insights into mechanisms of resistance to RAF inhibitors, potentially guiding future therapeutic strategies.
More Related Videos
Related Concept Videos
MAPK Signaling Cascades
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Intracellular Signaling Affects Focal Adhesions
Some...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...

